Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20754322 | 0.87 | SHBG (0.50) | TAAR1SHBGHIF1AESR1ESR2 | |
| SCHEMBL42933 | 0.80 | SHBG (0.60) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL2270630 | 0.78 | TAAR1 (0.56) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL29291029 | 0.76 | TAAR1 (0.54) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL21245467 | 0.76 | TAAR1 (0.54) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL8529366 | 0.76 | TAAR1 (0.54) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL7765635 | 0.76 | TAAR1 (0.54) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL9250206 | 0.76 | TAAR1 (0.54) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL19033678 | 0.76 | TAAR1 (0.60) | TAAR1MAPK1SHBGCYP2C19HIF1A | |
| SCHEMBL8730213 | 0.75 | TAAR1 (0.58) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079719-A1 | NOVEL THIOL COMPOUND COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079719-A1 | NOVEL THIOL COMPOUND COMPOSITION FOR OPTICAL MATERIAL | TMT1A, TXNL1, C5 | TAAR1 1518/4885MAPK1 3320/4885SHBG 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.